Frutarom Switzerland, Health BU Switzerland, in conjunction with Aquanova, Darmstadt, Germany, has announced the results of a recently published human study examining the bioavailability of curcumin across three different oral delivery systems.
Recognised as the most biologically active compound found in the turmeric rhizome (Curcuma longa), curcumin presents wide-ranging health benefits. Key to capitalising on curcumin’s health benefits is improving its limited uptake into the body.
The typically low systemic bioavailability of the lipophilic curcumin is attributed to its poor solubility in the aqueous phase of the digestive tract and its rapid metabolism and excretion from the body.
Over the past several years, new delivery systems have emerged and were touted for their potential to enhance uptake and retention.
The study, Oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes, provides strong data demonstrating enhanced systemic uptake and sustained circulation of NovaSOL curcumin micelles in comparison to native curcumin and curcumin micronisate.
“The numbers are exciting,” said Jan Frank PhD, professor at Hohenheim University’s Institute of Biological Chemistry and Nutrition in Stuttgart, and the principal investigator on the recently published human trial. “The AUC-[the area under the plasma concentration-time curve, which is the gold standard measurement of the bioavailability of a compound] places the NovaSOL curcumin micelle head and shoulders above other delivery systems. This provides significant opportunities to truly utilise curcumin’s properties to maximum effect.”
Based on comparisons of plasma AUC, the study demonstrates significant differences between the three curcumin formulations, with total AUC as follows: native curcumin 66 +/- 116 nmol/L×h, curcumin micronisate 583 +/- 289 nmol/L×h, and curcumin micelle 12148 +/- 4547 nmol/L×h.
The numbers show a 185-fold higher AUC, demonstrating conclusively the superior bioavailability of the curcumin micelle compared to native curcumin. Therefore, using a small, single dose of NovaSOL curcumin is the bioavailable equivalent to high, multiple-gram dosages of a standard extract.
Further studies, including an exploration of the differences in plasma concentration between men and women and the bio-efficacy of micellar curcumin, are under way at Professor Frank’s laboratories.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial